Med Life SA · BVB:M

Med Life SA — Q3 2017 Earnings Presentation

13 slides from Med Life SA's earnings presentation, 2017

  1. Slide 1: Conference Call Presentation for Q3 2017 Results

    Conference Call Presentation for Q3 2017 Results

  2. Slide 2: Legal Disclaimer

    LEGAL DISCLAIMER This presentation is not, and nothing in it should be construed as, an offer, invitation or recommendation in respect of Med Life SA’s securities, or an offer, invitation or recommendation to sell, or a solicitation of an offer to buy Med Life SA’s securities. Neither this presentat

  3. Slide 3: Topics of Discussion

    TOPICS OF DISCUSSION I. CAPITAL RAISE PROCESS STATUS 4 II. MAIN EVENTS OF 2017 5  Polisano acquisition 5  EGSM Decisions 6  Other events 7 III. MEDLIFE 9M 2017 FINANCIAL SNAPSHOT 8 IV. KEY OPERATIONAL METRICS FOR 9M 2017 11 V. Q&A SESSION

  4. Slide 4: I. Capital Raise Process Status

    I. CAPITAL RAISE PROCESS STATUS Current status • Prospectus submitted for approval to the Financial Supervisory Authority of Romania. Subscription period and Subscription rights • Shareholders registered in the Company's shareholder register as of 27th of October 2017 (“Record Date”) have been grant

  5. Slide 5: Polisano acquisition

    II. MAIN EVENTS OF THE FIRST 9 MONTHS OF 2017 Polisano acquisition MedLife signed in October the acquisition of 100% stake in Polisano medical services, one of the largest private medical operators in Romania. Founded in the 90’s, Polisano is the first fully integrated medical group in Romania. It i

  6. Slide 6: Extraordinary General Shareholders Meeting decisions

    II. MAIN EVENTS OF THE FIRST 9 MONTHS OF 2017 Extraordinary General Shareholders Meeting decisions Shareholders authorization for the Board of Directors to : • increase the share capital of the Company and • to opt for financing by carrying out one or several bond issues up to EUR 60 million PROCESS

  7. Slide 7: Other events

    II. MAIN EVENTS OF THE FIRST 9 MONTHS OF 2017 Other events Med Life SA signed the sales purchase agreement for the acquisition of shares/social parts of the share capital of the following companies: • 80% of share capital of Almina Trading SA – acquisition completed on the in March 2017 • 100% of sh

  8. Slide 8: III. MedLife Group 9M 2017 Financial Snapshot

    III. MEDLIFE GROUP 9M 2017 FINANCIAL SNAPSHOT Group sales increased with RON 97.69 mil, or 27%, in the 9M 2017 as compared to 9M 2016, amounting to RON 459.18 mil. Operating profit recorded a 154.4% increase YoY, from RON 11.44 mil in 9M 2016 to RON 29.1 mil in 9M 2017. Financial loss increased in 9

  9. Slide 9: III. MedLife Group 9M 2017 Financial Snapshot

    III. MEDLIFE GROUP 9M 2017 FINANCIAL SNAPSHOT Consolidated Statement of Financial Position Consolidated Statement of Cash Flow Description 31-Dec-16 30-Sep-17 % VAR Description 30-Sep-16 30-Sep-17 Non-current assets 375,364,713 428,121,614 14.1% Operating cash flow before working capital changes 55,

  10. Slide 10: Opex Evolution

    III. MEDLIFE GROUP 9M 2017 FINANCIAL SNAPSHOT OPEX EVOLUTION % of OPERATING EXPENSES % of SALES 9M 2016 9M 2017 Description % VAR 9M 2016 9M 2017 % change 9M 2016 9M 2017 % change IFRS IFRS Consumable materials and repair materials 60,878,765 73,407,079 20.6% 17.4% 16.9% -0.5 p.p 16.8% 16.0% -0.9 p.

  11. Slide 11: IV. Key Operational Metrics for 9M 2017

    IV. KEY OPERATIONAL METRICS FOR 9M 2017 Business Line FY 2016 9M 2017 Clinics sales 130,109,363 123,033,421 Visits 909,132 853,854 Average charge 143.1 144.1 1850313062% Stomatology sales 18,504,217 28,062,823 Visits 69,111 76,259 Average charge 267.7 368.0 3085365% Hospitals sales 104,977,229 88,24

  12. Slide 12: V. Q&A Session

    © Med Life V. Q&A SESSION eo Ras

  13. Slide 13: Thank you!

    Thank you! © MedLife

Med Life — Q3 2017 Earnings Presentation on 6ix